great penny stocks


As recently as last week, many high quality closed-end funds (CEFs) were being neglected thanks to the headline worry that higher rates would hurt them.

That nonsense stopped abruptly when Fed chair Janet Yellen basically slapped a “Buy” rating on the entire sector! Her dovish outlook was taken as a cue that CEF investors could breathe easy and, once again, collect their 8% yields in peace.

This cue was unnecessary. For starters, anyone who mistook Yellen’s Fed as hawkish was, well, mistaken. And has been for years.

Also, higher rates don’t really hurt CEFs.

The theory scares people because it sounds true. Closed-ends have the benefit of borrowing money at Libor to lever up their returns. Libor is tied closely to the Fed funds rate. So, the thinking goes, higher Fed rates will end the “cheap money” party that benefits CEFs.

great penny stocks: PCM, Inc.(PCMI)


Advisors’ Opinion:

  • [By Lisa Levin]

    PCM Inc (NASDAQ: PCMI) was down, falling around 26 percent to $14.63. PCM reported Q2 adjusted earnings of $0.47 per share on sales of $560.1 million.

great penny stocks: Alimera Sciences, Inc.(ALIM)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Thursday, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Alimera Sciences Inc (NASDAQ: ALIM) and Anthera Pharmaceuticals Inc (NASDAQ: ANTH).

  • [By Lisa Levin]

    Alimera Sciences Inc (NASDAQ: ALIM) shares shot up 59 percent to $1.69 after the company reported preliminary Q2 revenue. Alimera Sciences announced preliminary revenue of $9.3 million to $9.5 million.

great penny stocks: Codexis, Inc.(CDXS)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggested taking a long/bullish position in small cap biocatalysts developer Codexis, Inc (NASDAQ: CDXS):

  • [By Maxx Chatsko]

    While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).

great penny stocks: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Rofin-Sinar Technologies (NASDAQ: RSTI) got a boost, shooting up 37 percent to $31.50 as Coherent, Inc. (NASDAQ: COHR) announced its plans to buy Rofin-Sinar Technologies Inc in a deal valued at around $942 million.

Leave a Reply

Your email address will not be published.